The Danish biotech’s recruitment drive began last summer when data from an early-stage trial of the drug—petrelintide—showed ...

Royalty Pharma (RPRX) announced the appointment of Vlad Coric to the company’s board of directors, effective immediately. Vlad Coric is the chairman and CEO of Biohaven (BHVN). Published first ...

Shares of pharmaceutical companies got hammered down in the Monday stock market meltdown amid the tariff war set in motion last week by the U.S. with its reciprocal tariffs. All 20 companies ...

After reiterating that he would be putting a 104 percent retaliatory tariff on China at 12:01 a.m. Wednesday, Trump said his administration would soon be tariffing pharmaceuticals too. ' ...

Speaking aboard Air Force One, Trump signalled a fresh approach to trade restrictions, stating that pharmaceuticals would be treated separately under the "Liberation Day" tariff plan. This contradicts ...

World shares slumped on Wednesday after U.S. President Donald Trump’s latest tariff hikes took effect and he threatened to ...

The EU executive and top pharmaceutical companies shared a video call to address concerns over potential US tariffs on drugs ...

Sea Pharmaceuticals announced its selection of Inotiv (NOTV) for pre-clinical development IND-enabling studies to support the advancement of Sea’s lead molecule SPM-0404 as a potential new oral ...

New facility will provide cost-effective manufacturing and clinical testing for pharma and contract research organisations of all sizes. Significant increase in technical positions at BDD helping ...

In this edition of Data Spotlight, we look at economic estimates to refine forecasts, leveraging loans data for better ...

Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday. A total of 106 patients with ...